APA (7th ed.) Citation

Fallowfield, L., Gagnon, D., Zagari, M., Cella, D., Bresnahan, B., Littlewood, T. J., . . . Group, E. A. S. (2002). Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy. British Journal of Cancer, 87(12), 1341.

Chicago Style (17th ed.) Citation

Fallowfield, L., et al. "Multivariate Regression Analyses of Data from a Randomised, Double-blind, Placebo-controlled Study Confirm Quality of Life Benefit of Epoetin Alfa in Patients Receiving Non-platinum Chemotherapy." British Journal of Cancer 87, no. 12 (2002): 1341.

MLA (9th ed.) Citation

Fallowfield, L., et al. "Multivariate Regression Analyses of Data from a Randomised, Double-blind, Placebo-controlled Study Confirm Quality of Life Benefit of Epoetin Alfa in Patients Receiving Non-platinum Chemotherapy." British Journal of Cancer, vol. 87, no. 12, 2002, p. 1341.